HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG
HeartSciences Inc. announced it has received FDA 510(k) clearance for its MyoVista wavECG device, which functions as a 12-lead resting electrocardiograph.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
HeartSciences Inc. announced it has received FDA 510(k) clearance for its MyoVista wavECG device, which functions as a 12-lead resting electrocardiograph.